Peribronchiolar fibrosis is an important feature of small airway remodeling (SAR) in cigarette smoke-induced COPD. The aim of this study was to investigate the role of gelatinases (MMP9, MMP2) and epithelial-mesenchymal transition (EMT) in SAR related to wood smoke (WS) exposure in a rat model.
Forty-eight female Sprague-Dawley rats were randomly divided into the WS group, the cigarette smoke (CS) group and the clean air control group. After 4 to 7 months of smoke exposure, lung tissues were examined with morphometric measurements, immunohistochemistry and Western blotting. Serum MMP9 and TIMP1 concentrations were detected by ELISA. In vitro, primary rat tracheal epithelial cells were stimulated with wood smoke condensate for 7 days.
The COPD-like pathological alterations in rats exposed chronically to WS were similar to those exposed to CS; the area of collagen deposition was significantly increased in the small airway walls of those exposed to WS or CS for 7 months. The expression of gelatinases in rats induced by WS or CS exposure was markedly increased in whole lung tissue, and immunohistochemistry showed that MMP9, MMP2 and TIMP1 were primarily expressed in the airway epithelium. The serum levels of MMP9 and TIMP1 were significantly higher in rats secondary to WS or CS exposure. Few cells that double immunostained for E-cadherin and vimentin were observed in the airway subepithelium of rats exposed to WS for 7 months (only 3 of these 8 rats). In vitro, the expression of MMP9 and MMP2 proteins was upregulated in primary rat tracheal epithelial cells following exposure to wood smoke condensate for 7 days by Western blotting; positive immunofluorescent staining for vimentin and type I collagen was also observed.
Citation: Zou Y, Li S, Zou W, Hu G, Zhou Y, Peng G, et al. (2014) Upregulation of Gelatinases and Epithelial–Mesenchymal Transition in Small Airway Remodeling Associated with Chronic Exposure to Wood Smoke. PLoS ONE9(5): e96708. https://doi.org/10.1371/journal.pone.0096708
Editor: Oliver Eickelberg, Helmholtz Zentrum München/Ludwig-Maximilians-University Munich, Germany
Received: October 23, 2013; Accepted: April 10, 2014; Published: May 6, 2014
Copyright: © 2014 Zou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Natural Science Foundation of China (81170043), National Natural Science Foundation of Guangdong (S2011020002789), and Doctoral Fund of Ministry of Education of China (2010442311 0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation, which is usually progressive and classically involves clinical or pathological presentations (chronic bronchitis, emphysema and small airway disease) . Cigarette smoking accounts for approximately 80–90% of COPD cases in the United States . Biomass smoke (wood, dung, or straw) derived from household cooking and heating is another leading cause of COPD, mostly in developing countries . Patients exposed to biomass smoke can present with emphysema and other lesions observed in cigarette smokers, but they show more lung fibrosis than cigarette smokers ; these indications are unclear in the pathogenesis of COPD secondary to biomass smoke exposure.
Small airway remodeling (SAR), rather than emphysema, is the major cause of airflow limitation in COPD . Peribronchiolar fibrosis has been speculated as the key factor in the fixed airway obstruction in the small airways of patients with COPD associated with cigarette smoke . Tissue fibrosis occurs when equilibrium is lost between the deposition and degradation of the extracellular matrix (ECM). Matrix metalloproteinases are a family of zinc-dependent endopeptidases that are involved in the breakdown and remodeling of the ECM .
Very little is known about the role of matrix metalloproteinases in the SAR in COPD, although there is a widespread belief that matrix metalloproteinases account for matrix disruption and airspace enlargement in the pathogenesis of emphysema . Some studies have shown the increased expression and activity of MMP9 and MMP2 in the sputum, bronchoalveolar lavage fluid and peripheral blood from patients with COPD, and MMP9 and MMP2 may contribute to the severity of airflow limitation during COPD progression , . TIMP1 is a natural inhibitor of MMPs (mainly MMP9), which inhibits matrix metalloproteinases in a 1: 1 stoichiometric and reversible manner . An imbalance of MMP9 with TIMP1 might be involved in the pathogenesis of airway obstruction in COPD . However, the induced sputum is derived from the central airways with little or no contribution from the peripheral airways; and bronchoalveolar lavage fluid cannot be discriminated by its source, which includes the individual components of the distal airway and alveolar compartments . The role of MMP9 and MMP2 in SAR in COPD needs to be studied through direct analyses of airway tissues.
Fibroblasts are believed to be the major cells responsible for the production and maintenance of the ECM . Recently, one potential mechanism contributing to airway fibrosis is the transition of airway epithelial cells to fibroblast phenotypes, a process termed epithelial-mesenchymal transition (EMT) . Evidence for EMT in the airway remodeling in COPD patients secondary to cigarette smoke has been reported by Sohal  and Milara . However, whether EMT is present in the SAR in COPD induced by biomass smoke exposure remains to be elucidated.
There are few animal models of COPD related to biomass smoke exposure. One recent study has shown the role of MMP9 and MMP2 in emphysema secondary to wood smoke (WS) exposure in a guinea pig model . The present work was to study the role of gelatinases and EMT in SAR in COPD associated with chronic exposure to WS in a rat model.
Materials and Methods
All animal experiments were approved by the Local Ethics Committee of Guangzhou Medical University.
Forty-eight female Sprague-Dawley rats (body weight 180–220 g, 8–9 weeks old) were housed in the laboratory animal center of Guangzhou Medical University. Rats were randomly divided into the WS group, the cigarette smoke (CS) group and the clean air control group.
Exposure to WS
Rats were exposed to smoke produced by smoldering China fir sawdust (10 g/per time) for 45 minutes, 4 times per day, 7 days per week for 4 to 7 months. The whole-body WS exposure apparatus primarily consisted of a wood burning stove, a piston pump and an inhalation chamber (Figures 1A and 1C). The WS generated by the burning stove was sent into the inhalation chamber through a piston pump (2.5 L/min). The fresh air was sent into the inhalation chamber by a mini air pump (1.5 L/min). The size of the inhalation chamber was 80×60×60 cm. In this manner, WS flowed from the burning stove to the inhalation chamber and then to the outside.
(A) The WS exposure apparatus primarily consisted of a wood burning stove, a piston pump and an inhalation chamber. (B) The CS exposure apparatus primarily consisted of a cigarette burning box, a piston pump and an inhalation chamber. (C) The wood burning stove had four independent heating wires (300 W), and the small iron trays were placed on the heating wire to smolder the wood sawdust. (D) The cigarette burning box had five cigarette holders.
The CO and O2 concentrations in the inhalation chamber were monitored with a detector (M40 Multi-Gas Monitor; Oakdale, PA, USA); PM10 concentrations were measured with an automatic dust monitor (P-5L2C; Peking, China). During WS exposure, the concentrations of CO, O2 and PM10 were 539.3±309.8 ppm, 20.2±0.4% and 27.6±12.1 mg/m3, respectively.
Exposure to CS
Rats were exposed to the smoke generated by 5 cigarettes (Cocopalm, Guangzhou, China; tar 12 mg and nicotine 1.2 mg) for 45 minutes, 4 times per day, 7 days per week for 4 to 7 months. The whole-body CS exposure apparatus primarily consisted of a cigarette burning box, a piston pump and an inhalation chamber (Figures 1B and 1D). The mainstream smoke was drawn into the inhalation chamber by a piston pump, according to the Federal Trade Commission protocol (1 puff/min of 2 sec duration and 35 ml volume); the sidestream smoke was sent into the inhalation chamber by a fan. A mini air pump was used for the air supplement into the inhalation chamber (1.5 L/min). During CS exposure, the concentrations of CO, O2 and PM10 were 467.2±98.1 ppm, 20.1±0.4% and 20.5±9.9 mg/m3, respectively.
Sampling the Lung Tissues and Blood
Rats were sacrificed by the intraperitoneal injection of sodium pentobarbital (50 mg/kg). The left lungs were inflated and fixed using 4% phosphate-buffered formaldehyde (pH 7.40) at 25 cm H2O pressure for 24 h. The lungs were then embedded in paraffin and cut into 4 µm thick sections. The right lung tissues were snap frozen in liquid nitrogen and stored at −80°C for Western blot analysis. Blood samples were taken from the inferior vena cava, and the serum was stored at −80°C for ELISA.
To avoid observer bias, all microscope slides were coded before analysis by one observer and were read blindly. Photographs were taken on a Zeiss Axio Imager 2 Microscope (Carl Zeiss, Germany), and morphometric analyses were quantified using Image-Pro Plus (IPP) 6.0 software (Media Cybernetics, Silver Spring, USA).
Airspace size was quantified in lung tissues stained with H&E using the mean linear intercept . The thickness of the small airway wall was analyzed according to methods described previously . Small airways cut transversely and with a basement membrane perimeter (Pbm) less than 1000 µm were examined. The results were standardized for airway size using the Pbm (µm2/µm). At least five small airways were counted on each slide. The area of the small airway wall stained with Masson's Trichrome was quantified as described previously .
Immunohistochemical (IHC) evaluation was performed as described elsewhere . Tissue sections were deparaffinized, rehydrated and blocked with H2O2 (3%) for 15 minutes, followed by antigen retrieval performed with citrate buffer (10 mM, pH 6.0) for 15 minutes in a microwave. Tissue sections were treated with normal goat serum (5%) at room temperature (RT). Subsequently, the sections were incubated overnight at 4°C with primary antibodies against MMP9, MMP2, type I collagen, FSP1, vimentin, E-cadherin (Abcam; Cambridge, UK), TIMP1 (Millipore; USA), and α-SMA (Sigma-Aldrich). A horseradish peroxidase (HRP)-conjugated secondary antibody was used and visualized with diaminobenzidine using a Immunohistochemistry Detection Kit (Gene Tech; Shanghai, China), according to the manufacturer's protocols. Double IHC staining of E-cadherin (BD Biosciences; California, USA) and vimentin or FSP1 (Abcam; Cambridge, UK) was performed using the MultiVision polymer detection system (Thermo Scientific; Utah, USA) according to the manufacturer's protocols.
Photographs were taken using identical conditions for light setting and contrast. The color segmentation protocols were utilized in the IPP6.0 system to obtain the data. The area of α-SMA and type I collagen immunostaining in the small airway wall was quantitatively analyzed . The expression of MMP9, MMP2 and TIMP1 in the small airway wall was quantified by measuring the integrated optical density (IOD) of the positive staining area. The number of fibroblasts in the small airway wall was quantified as the number of positively stained FSP1 and spindle-shaped cells per µm length of basement membrane.
Western Blot Analysis
The lung protein levels of MMP9 and MMP2 were evaluated by Western blotting as previously described . After the lung tissues were lysed in RIPA buffer (Pierce Biotechnology; Rockford, USA), the proteins were quantified using a Pierce BCA protein assay kit (Thermo Scientific; Utah, USA). Equal amounts of total protein were resolved on 8% SDS-PAGE electrophoresis. Following electrophoretic transfer, the membranes were treated at RT for 1 hour with 5% skim milk. Then, the membranes were incubated overnight at 4°C with primary antibodies against MMP9, MMP2 (Abcam; Cambridge, UK), and β-tubulin (Santa Cruz Biotechnology; California, USA). The membranes were then incubated with secondary antibodies conjugated to HRP (Santa Cruz Biotechnology; California, USA). Immunodetection was performed by chemiluminescence (ECL, Millipore). Relative protein levels were quantified and normalized by β-tubulin protein levels. Total cellular extracts were obtained and Western blotting was performed as described previously .
MMP-9 and TIMP-1 measurement by ELISA
The levels of serum MMP-9 and TIMP-1 were detected using MMP-9 and TIMP-1 ELISA kits (R&D Systems; Minneapolis, USA). All samples were measured in duplicate, and the average values were used.
Cell Culture Stimulated by Wood Smoke Condensate and Immunofluorescence
Wood smoke condensate was obtained as previously described . Primary rat tracheal epithelial cells (ATCC; Manassas, VA, US) were cultured in a humidified atmosphere of 5% CO2 at 37°C. Prior to the experiments, the cells were serum starved for 24 h and then stimulated with 10 µg/ml of wood smoke condensate diluted in growth medium (containing 0.3% FBS) for 7 days. Then, the cells were harvested for immunofluorescence,cell lysis and protein extraction. The cells were fixed in 4% (w/v) paraformaldehyde for 15 minutes and were then incubated with primary antibodies (E-cadherin, vimentin, Type I collagen) and detected using an appropriate fluorochrome- linked secondary antibody. DAPI was used as a nuclear counterstain. Images were acquired using a Zeiss Axio Imager 2 Microscope (Carl Zeiss, Germany).
Histological Morphometric Analysis
Histological analysis revealed the presence of emphysematous lesions and small airway wall thickening in rats exposed to smoke (Figures 2a–f). At 7 months, the mean linear intercept difference was significant between the controls (47.7±4.0 µm) and the WS group (60.5±6.7 µm, p<0.01) or the CS group (56.1±4.1 µm, p<0.05) (Figure 2g). The difference in the thicknesses of the small airway wall was markedly significant between the controls (7.6±1.1 µm2/µm) and the WS group (14.3±3.3 µm2/µm, p<0.01) or the CS group (12.1±3.4 µm2/µm, p<0.01) (Figure 2h).
(a–c, g) Photomicrograph and graphical data demonstrating that the airspace size increased significantly in rats exposed to WS or CS for 7 months. (d–f, h) Photomicrograph and graphical data showing that the thickness of the small airway wall (SAW) increased significantly in rats exposed to WS or CS for 7 months. Data are shown as the mean ± SEM. n = 8 animals/group. Overall comparisons were made using one-way ANOVA (p<0.05). Scale bar = 50 µm.
Airway Smooth Muscle Thickness
The thickness of the airway smooth muscle was quantified using the area of α-SMA IHC staining. Neither WS nor CS induced a statistically significant increase in the thickness of the small airway smooth muscle (p>0.05) (Figure 3).
Increased Collagen Deposition in Small Airway Walls
The change in the level of small airway fibrosis was assessed by Masson's Trichrome staining and type-I collagen IHC staining methods (Figures 4a–f). After 4 months of smoke exposure, there were no significant differences in collagen deposition between the groups. At 7 months, both the WS group (4.9±2.2 µm2/µm, p<0.05) and the CS group (4.9±1.0 µm2/µm, p<0.05) exhibited significantly more collagen deposition in the small airway wall than the controls (2.4±1.1 µm2/µm) (Figure 4g). Additionally, the area of type-I collagen staining in the small airway wall was significantly higher in the WS group (11.1±2.7 µm2/µm, p<0.05) and the CS group (10.5±2.5 µm2/µm, p<0.05) than in controls (7.0±2.1 µm2/µm) (Figure 4h).
(a–f) Masson's Trichrome staining and IHC staining for Type I collagen showed increased collagen deposition in the small airway wall after 7 months of smoke exposure. (g, h) Graphical data showed that the area of total collagen and type I collagen deposition in the small airway wall exposed to WS or CS was significantly increased compared to controls at 7 months, but there was no significant difference at 4 months. Data are shown as the mean ± SEM or as box and whisker plots with the median, minimum and maximum values. n = 8 animals/group. Scale bar = 50 µm.
Increased Expression of MMP9, MMP2 and TIMP1
MMP9, MMP2 and TIMP1 immunostaining was primarily localized in airway epithelial cells, as well as infiltrating inflammatory cells and fibroblasts (Figures 5A–C). Moreover, the IODs of MMP9, MMP2 and TIMP1 immunostaining in the WS group and the CS group were significantly higher than those in controls at 4 or 7 months (Figures 5D–F).
(A–C) Photomicrograph data showing the IHC staining pattern for MMP9, MMP2 and TIMP1 in small airway walls exposed to smoke for 7 months. MMP9, MMP2 and TIMP1 immunostaining was primarily localized in airway epithelial cells, infiltrating inflammatory cells and fibroblasts. (g, h) Graph showing that the IODs of MMP9, MMP2 and TIMP1 increased significantly in the small airway wall secondary to WS or CS exposure for 4 to 7 months. Data are shown as the mean ± SEM. n = 8 animals/group. Scale bar = 50 µm.
In whole lung tissue and cellular protein extraction, western blotting revealed lysis bands of estimated molecular weights of 78 KD (MMP9), 74 KD (MMP2) and 55 KD (β-tubulin) in the samples. The expression levels of MMP9 and MMP2 in the WS group and the CS group were markedly increased in comparison with controls (Figures 6A and 6B). And wood smoke condensate induced the increased expression of MMP9 and MMP2 proteins in primary rat tracheal epithelial cells (Figures 6E and 6F).
Western blot analysis of MMP9 protein expression (78 KD) in the lung tissues from each group is shown in (A); MMP2 protein expression (74 KD) in (B). Graph showed that the relative intensity of MMP9/β-tubulin protein expression or MMP2/β-tubulin protein expression was higher in lung tissues after smoke exposure for 4 to 7 months compared to controls. (C, D) The levels of serum MMP9 and TIMP1 were significantly higher in the WS group and the CS group than in controls. (E, F) Wood smoke condensate induced an increased expression of MMP9 and MMP2 proteins in primary rat tracheal epithelial cells by Western blotting. Data are shown as the mean ± SEM or as box and whisker plots with the median, minimum and maximum values. n = 8 animals/group.
The Serum Levels of MMP9 and TIMP1
At 7 months, the levels of serum MMP9 and TIMP1 were significantly higher in the WS group and the CS group than in controls, but there were no significant differences between the WS group and the CS group (Figures 6C and 6D).
Increased Fibroblasts in Small Airway Walls
Immunostaining for anti-FSP1 clearly demonstrated that spindle-shaped fibroblasts were present in the small airway subepithelium and adventitial compartment (Figure 7A). The number of fibroblasts in the small airway wall was significantly higher in the WS group and the CS group than in controls (Figure 7B).
Immunostaining for FSP1 and spindle-shaped cells in small airway walls following smoke exposure for 7 months is shown in (A). (B) Graph showing that the number of fibroblasts increased significantly in small airway walls exposed to WS or CS for 4 to 7 months. Data are shown as the mean ± SEM. n = 8 animals/group. Scale bar = 50 µm.
Expression of EMT Markers
Although the airway epithelium in rats following exposure to WS did not show a marked decrease in E-cadherin immunostaining compared with controls, positive staining for mesenchymal markers (FSP1, vimentin, α-SMA) was sometimes observed in the small airway epithelium at 7 months (Figure 8A). Furthermore, Figures 8B and 8C showed the small number of cells that double immunostained for E-cadherin and vimentin or FSP1 in the airway subepithelium of rats exposed to WS at 7 months (only 3 of these 8 rats). In vitro, primary rat tracheal epithelial cells had a cobble stone morphology, but a morphological phenotype characteristic of EMT was observed in the presence of wood smoke condensate, with loss of cell-cell contact and an elongated shape (Figure 9A). In addition, immunofluorescent staining showed that the expression of E-cadherin decreased in primary rat tracheal epithelial cells after 7 days of treatment with wood smoke condensate, and the expression of vimentin and type I collagen was observed (Figures 9B and 9C).
(A) Photomicrographs showing that the small airways immunostained for E-cadherin, FSP1, vimentin and α-SMA. Although the airway epithelium in rats exposed to WS did not show a marked decrease in E-cadherin immunostaining compared to controls, the positive staining of mesenchymal markers (FSP1, vimentin, α-SMA) was sometimes observed in the small airway epithelium at 7 months. (B, C) Photomicrographs showing the small number of cells that double immunostained for E-cadherin and vimentin or FSP1 in the airway subepithelium of rats exposed to WS for 7 months (only 3 of these 8 rats). Black arrows show positively immunostained cells. Scale bar = 50 µm.
(A) Wood smoke condensate induced a mesenchymal morphology. (B, C) Immunofluorescent staining showed that wood smoke condensate induced a downregulation of the epithelial marker (E-cadherin) and an upregulation of the mesenchymal markers (vimentin and type I collagen) in primary rat tracheal epithelial cells. Scale bar = 50 µm.
The household use of wood and other biomass fuels is a frequent practice worldwide, but the respiratory effects of chronic exposure to WS have scarcely been investigated . Although SAR is an important cause of airflow obstruction, very little is known about its pathogenesis. The present study showed that the pathological changes in the rat respiratory tract following chronic exposure to WS were similar to those in rats exposed to CS. The expression of MMP9, MMP2 and TIMP1 was markedly increased in the small airway walls of rats exposed to WS, and the expression was primarily located in the airway epithelium. Moreover, the serum MMP9 and TIMP1 concentrations were significantly increased in rats exposed to WS or CS. The number of fibroblasts was markedly increased in the subepithelium and outer walls of small airways chronically exposed to WS. Staining for mesenchymal markers and double IHC staining showed that partial airway fibroblasts may derive directly from bronchial epithelial cells via EMT. In vitro, the expression of MMP9 and MMP2 proteins was upregulated in primary rat tracheal epithelial cells following exposure to wood smoke condensate for 7 days; and positive immunofluorescent staining for vimentin and type I collagen was also observed. Our results suggest that gelatinases and EMT might play a role in SAR in COPD induced by chronic WS exposure.
China firs are widely used for daily cooking in the rural areas of China. CO is an indicator of wood smoke exposure and the largest constituent of incomplete combustion . A baseline survey in Zimbabwe showed that the levels of CO in the kitchen during cooking were in the range of 300–1,000 ppm . In our study, the CO concentration in rats exposed to WS was consistent with those levels.
The present study demonstrated that the COPD-like pathological alterations in rats exposed to WS were similar to those in rats exposed to CS, consistent with the results of a previous human study . Wood smoke contains thousands of chemical components, including fine particles, CO, nitrogen oxides, respiratory irritants and other toxic organic compounds, which have adverse effects on human health . Previous research has shown that women exposed to biomass smoke can develop airflow limitation . SAR leads to airway wall thickening and fixed airway obstruction . In the present study, although there was a small increase in smooth muscle thickness in rats exposed to smoke, the difference was not significant. In contrast to asthma, the airway smooth muscle in COPD patients may play a relatively minor role in airway remodeling. Our results demonstrated that the amounts of both total collagen and type I collagen were significantly increase in small airways chronically exposed to WS. Type I collagen is a major matrix element that resists tensile stresses in the lung, and thus, alterations in type I collagen at the distal level might contribute to airway-parenchyma structural changes, such as airway obstruction .
The present study showed that the expression of MMP9, MMP2 and TIMP1 was markedly increased in small airway walls and whole lung tissue in rats exposed to smoke; serum MMP9 and TIMP1 concentrations were also significantly higher in rats secondary to WS or CS when compared with controls. In vitro, wood smoke condensate induced the increased expression of MMP9 and MMP2 proteins in primary rat tracheal epithelial cells. Montaño et al. had demonstrated that the expression and gelatinolytic activity of MMP9 and MMP2 were significantly increased in bronchoalveolar lavage fluid from COPD patient associated with wood smoke . Carlos Ramos et al.  reported that increases in MMP9 and MMP2 activity and expression could be responsible for emphysematous lesions induced by wood smoke exposure in guinea pigs. The present results are in accordance with those conclusions, which the upregulation of MMP9 and MMP2 could lead to pulmonary emphysema in rats exposed to WS. Furthermore, our results suggest that the increased expression of MMP9 and MMP2 might play a role in collagen deposition in small airway walls in rats. This might seem counterintuitive since proteinases degrade matrix. However, the net effect on collagen depends on whether a particular proteinase can degrade collagen as well as other non-matrix substrates . It has been reported that MMP9 and to a lesser extent MMP2, can cleave a variety of non-ECM proteins, such as certain chemokines, growth factors and amyloid beta peptide . In addition, MMP9 and MMP2 can directly process TGF-β into an active ligand and induce TGF-β1 production in the airway epithelium and peribronchiolar fibroblast proliferation . TIMP1 is significantly higher in rats exposed to wood smoke than in control subjects, suggesting the existence of a protease–antiprotease imbalance. Deregulation of matrix metalloproteinases activities is a dynamic course, and leads to states of impaired repair and pathological tissue remodeling . Our results demonstrated that MMP9, MMP2 were mainly synthesized and secreted by airway epithelial cells. This study provided evidence indicating that the airway epithelium is a direct and main source of gelatinases in the small airway wall following to WS exposure. Therefore, MMP inhibitors administered by aerosol delivery might be an effective and safe treatment method, permitting local administration and a lower dose of medicine . The use of specific MMP inhibitors or knock-out mice will be of interest in the future to assess whether MMP9/MMP2 are crucial in wood-smoke induced development of COPD manifestations.
Fibroblasts and epithelial cells are the main effector cells during airway remodeling . A significant increase in the number of fibroblasts is observed in small airway walls following exposure to WS or CS. It has been established that fibroblast accumulation may occur as a consequence of resident fibroblast to myofibroblast transitions, the recruitment of circulating fibroblastic stem cells or EMT . FSP1, vimentin and α-SMA are widely used as mesenchymal biomarkers of EMT. In rats exposed to WS for 7 months, the positive staining of mesenchymal markers was sometimes observed in the airway epithelium; few cells that double immunostained for E-cadherin (epithelial marker) and vimentin or FSP1 were observed in the airway subepithelium. In vitro, primary rat tracheal epithelial cells stimulated by wood smoke condensate presented a morphological phenotype characteristic of EMT; immunofluorescent staining showed that the expression of E-cadherin had decreased, and the expression of vimentin and type I collagen was observed. These results indicate that partial bronchial fibroblasts might originate directly from epithelial cells via EMT. A previous study in patients with cigarette smoke-induced COPD has shown that E-cadherin expression in the airway epithelium is significantly decreased during EMT . However, our results illustrate that E-cadherin immunostaining in rats exposed to WS was not markedly down-regulated; double positive IHC staining cells were found in only 3 of these 8 rats. We speculate that the wood smoke exposure index was not sufficiently strong; moreover, EMT is a long-term and dynamic process. It has been reported that the reticular basement membranes of smokers and COPD patients are highly fragmented with elongated spaces or cracks . MMP9 and MMP2 contain fibronectin type II-like repeats within their catalytic domains and primarily degrade type IV collagens, which are thought to assist epithelial cell migration by disrupting the underlying basement membrane . In addition, the present study demonstrated the destruction of alveolar structure, but mild fibrosis in lung tissues. We did not performed the double immunostaining with surfactant protein C (a biomarker of alveolar epithelial cell) and mesenchymal biomarkers. Unlike normal human alveolar type II epithelial cell, those isolated from the lungs of patients with idopathic pulmonary fibrosis express higher levels of mRNA for the mesenchymal proteins, which suggests the human alveolar type II epithelial cells could acquire features of mesenchymal cells via EMT. However, there are no clinical and experimental researches on the relationship between EMT and emphysema yet.
In summary, chronic exposure to WS produces COPD-like pathological alterations similar to CS in a rat model. The increased expression of MMP9 and MMP2 in small airway walls exposed to WS appears to play a role in peribronchiolar fibrosis, which then leads to small airway wall thickening. EMT is also likely involved in wood smoke-induced SAR. Understanding the roles that gelatinases and EMT play in SAR may aid the treatment of patients with COPD associated with chronic WS exposure.
Conceived and designed the experiments: Y. Zou GH BL PR. Performed the experiments: Y. Zou SL. Analyzed the data: Y. Zou WZ GP PR. Contributed reagents/materials/analysis tools: Y. Zou FH. Wrote the paper: Y. Zou Y. Zhou PR. Interpreted results of experiments: Y. Zhou GP BL PR.
- 1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187: 347–365.
- 2. Sethi JM, Rochester CL (2000) Smoking and chronic obstructive pulmonary disease. Clin Chest Med 21: : 67–86, viii.
- 3. Liu S, Zhou Y, Wang X, Wang D, Lu J, et al. (2007) Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 62: 889–897.
- 4. Rivera RM, Cosio MG, Ghezzo H, Salazar M, Perez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 12: 972–977.
- 5. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine 350: 2645–2653.
- 6. Wright J (1995) Emphysema: concepts under change—a pathologist's perspective. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 8: 873–880.
- 7. Oikonomidi S, Kostikas K, Tsilioni I, Tanou K, Gourgoulianis KI, et al. (2009) Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem 16: 1214–1228.
- 8. Mehra D, Geraghty PM, Hardigan AA, Foronjy R (2012) A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PloS one 7: e52889.
- 9. Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K (2008) Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 13: 1014–1021.
- 10. Brajer B, Batura-Gabryel H, Nowicka A, Kuznar-Kaminska B, Szczepanik A (2008) Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol 59: 145–152.
- 11. Lagente V, Boichot E (2010) Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol 48: 440–444.
- 12. Beeh K, Beier J, Kornmann O, Buhl R (2003) Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respiratory medicine 97: 634–639.
- 13. Bergeron C, Tulic M, Hamid Q (2007) Tools used to measure airway remodelling in research. European Respiratory Journal 29: 596–604.
- 14. Togo S, Holz O, Liu X, Sugiura H, Kamio K, et al. (2008) Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 178: 248.
- 15. Borthwick LA, Parker SM, Brougham KA, Johnson GE, Gorowiec MR, et al. (2009) Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 64: 770–777.
- 16. Sukhwinder S, David R, Amir S, Chris W, Konrad MH, et al.. (2011) Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 12..
- 17. Milara J, Peiró T, Serrano A, Cortijo J (2013) Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 68: 410–420.
- 18. Ramos C, Cisneros J, Gonzalez-Avila G, Becerril C, Ruiz V, et al. (2009) Increase of matrix metalloproteinases in woodsmoke-induced lung emphysema in guinea pigs. Inhalation toxicology 21: 119–132.
- 19. Hanaoka M, Droma Y, Chen Y, Agatsuma T, Kitaguchi Y, et al. (2011) Carbocisteine protects against emphysema induced by cigarette smoke extract in rats. CHEST Journal 139: 1101–1108.
- 20. Bracke K, D'hulst A, Maes T, Demedts I, Moerloose K, et al. (2007) Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice. Clinical & Experimental Allergy 37: 1467–1479.
- 21. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, et al. (2004) Immunostimulatory DNA inhibits transforming growth factor-β expression and airway remodeling. Am J Respir Cell Mol Biol 30: 651–661.
- 22. Selman M, Cisneros-Lira J, Gaxiola M, Ramírez R, Kudlacz EM, et al. (2003) Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs. CHEST Journal 123: 1633–1641.
- 23. Kohan M, Breuer R, Berkman N (2009) Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 41: 290–296.
- 24. Deng Y, Yang Z, Gao Y, Xu H, Zheng B, et al. (2013) Toll-Like Receptor 4 Mediates Acute Lung Injury Induced by High Mobility Group Box-1. PloS one 8: e64375.
- 25. Ning W, Dong Y, Sun J, Li C, Matthay MA, et al. (2007) Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. American journal of respiratory cell and molecular biology 36: 480.
- 26. Montano M, Beccerril C, Ruiz V, Ramos C, Sansores RH, et al. (2004) Matrix metalloproteinases activity in COPD associated with wood smoke. CHEST Journal 125: 466–472.
- 27. Dix-Cooper L, Eskenazi B, Romero C, Balmes J, Smith KR (2012) Neurodevelopmental performance among school age children in rural Guatemala is associated with prenatal and postnatal exposure to carbon monoxide, a marker for exposure to woodsmoke. Neurotoxicology 33: 246–254.
- 28. Mishra V (2003) Indoor air pollution from biomass combustion and acute respiratory illness in preschool age children in Zimbabwe. International Journal of Epidemiology 32: 847–853.
- 29. Rivera R, Cosio M, Ghezzo H, Salazar M, Pérez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. The International Journal of Tuberculosis and Lung Disease 12: 972–977.
- 30. Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, et al. (2007) Woodsmoke health effects: a review. Inhal Toxicol 19: 67–106.
- 31. Regalado J, Pérez-Padilla R, Sansores R, Paramo Ramirez JI, Brauer M, et al. (2006) The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. Am J Respir Crit Care Med 174: 901–905.
- 32. Dolhnikoff M, da Silva LF, de Araujo BB, Gomes HA, Fernezlian S, et al. (2009) The outer wall of small airways is a major site of remodeling in fatal asthma. Journal of Allergy and Clinical Immunology 123: 1090–1097
- 33. YL L, Sugar S (2002) Proteinases in chronic obstructive pulmonary disease. Biochemical Society Transactions 30..
- 34. Chakrabarti S, Patel KD (2005) Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 31: 599–621.
- 35. Perng DW, Chang KT, Su KC, Wu YC, Chen CS, et al. (2011) Matrix metalloprotease-9 induces transforming growth factor-beta(1) production in airway epithelium via activation of epidermal growth factor receptors. Life Sci 89: 204–212.
- 36. Gueders MM, Foidart J-M, Noel A, Cataldo DD (2006) Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. European journal of pharmacology 533: 133–144.
- 37. Daheshia M (2005) Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD). Current Medical Research and Opinion 21: 587–593.
- 38. Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annual Review of Pathological Mechanical Disease 4: 435–459.
- 39. Scotton CJ, Chambers RC (2007) Molecular Targets in Pulmonary FibrosisThe Myofibroblast in Focus. CHEST Journal 132: 1311–1321.
- 40. Soltani A, Reid DW, Sohal SS, Wood-Baker R, Weston S, et al. (2010) Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 11: 105.
- 41. Sohal SS, Reid D, Soltani A, Ward C, Weston S, et al. (2010) Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 15: 930–938.